HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.44
After Hours:(0.69%)-0.010
$1.43
Closed: Oct 15, 7:36:30 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$1.47
Day range
$1.41 - $1.52
Year range
$1.40 - $3.48
Market cap
47.51M USD
Avg Volume
576.70K
P/E ratio
-
Dividend yield
-
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.17M | 35.41% |
Net income | -5.35M | 39.78% |
Net profit margin | — | — |
Earnings per share | -0.17 | 58.02% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.14M | -12.39% |
Total assets | 11.05M | -8.10% |
Total liabilities | 7.17M | -19.06% |
Total equity | 3.88M | — |
Shares outstanding | 32.99M | — |
Price to book | 12.25 | — |
Return on assets | -112.74% | — |
Return on capital | -292.89% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.35M | 39.78% |
Cash from operations | -4.14M | 11.73% |
Cash from investing | — | — |
Cash from financing | 3.41M | -57.33% |
Net change in cash | -718.77K | -121.73% |
Free cash flow | -2.34M | 30.70% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
